Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Sivelestat as an Adjunct to Mechanical Thrombectomy in Acute LVO Stroke
NCT07196605Completed
- Sponsor
- Xuanwu Hospital
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sivelestat in ischemic stroke and Large vessel occlusion (LVO), sponsored by Xuanwu Hospital. Primary endpoint: modified Rankin Scale at 90 days. Started Oct 2025; status: completed.
02
Drugs
sivelestat
03
Conditions
ischemic strokeLarge vessel occlusion (LVO)
Beyond the preview
Go deeper on NCT07196605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07196605.